Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
Objective: To evaluate the cost utility of epidermal growth factor receptor (EGFR) testing plus first-line gefitinib treatment in patients with activating EGFR mutations in Thailand. Methods: The study used a decision tree model considering the provider's perspective. Direct medical costs were...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897471037&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |